Maja Artandi, MD
Academic Appointments
- Clinical Assistant Professor, Medicine - General Medical Disciplines
Key Documents
Contact Information
-
Clinical Offices
Stanford Internal Medicine 211 Quarry Rd., Suite 305 MC: 5987 Palo Alto, CA 94304 Tel Work (650) 723-6028 Fax (650) 725-7078
- Academic Offices
Personal Information EmailAlternate Contact Care Coordinator, Stanford Medical Group Tel Work (650) 723-6028Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Internal Medicine
- General Internal Medicine
Administrative Appointments
- Clinical Assistant Professor, Stanford Medical School (2009 - present)
- Clinical Instructor, Stanford Medical School (2006 - 2009)
- Clinical Instructor, Stanford Medical School (2005 - 2005)
- Medical Staff, Palo Alto Veteran Affairs Hospital (2004 - 2008)
Honors and Awards
- DGIM research award, Stanford Department of General Internal Medicine (2010)
- Exceptional Preceptor in the Ambulatory Medicine Clerkship, Stanford University (2006)
- Erasmus scholarship to study medicine in a foreign country, ERASMUS Programme (1997)
Professional Education
| Residency: | Stanford University Medical Center CA (2004) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (2004) |
| Internship: | Stanford University Medical Center CA (2002) |
| Residency: | Medizinische Hochschule Hannover, Germany (1999) |
| Medical Education: | Georg-August University Faculty Medicine, Germany (1997) |
| Residency: | Stanford Medical School, Internship and Residency (2004) |
Community and International Work
- Teaching Module, Stanford University
- Teaching Module, Stanford University
Scientific Focus
Publications
- TERT promotes epidermal proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 2008: (4) 1
- Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature. 2005; (7053): 1048-52
- Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo clinic regimen in the first line therapy of advance colorectal cancer Oncol Rep. 2005: 13 (4) 681-8
- Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A. 2002; (12): 8191-6
- Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology. 2001 May-Jun; (39): 783-9
- Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area Liver. 2000: 20 (4):312-8
